Lv5
1420 积分 2023-12-21 加入
Oral agents for lowering lipoprotein(a)
16天前
已完结
Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review
1个月前
已完结
Back in Person: Frontiers in Medicinal Chemistry 2023
1个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
1个月前
已完结
Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis
2个月前
已完结
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors
2个月前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
3个月前
已完结
IDL-2965: A Selective, highly-potent, oral Integrin antagonist for IPF
4个月前
已关闭
Prospective study design and data analysis in UK Biobank
4个月前
已完结
Small molecule approaches to targeting RNA
4个月前
已完结
皖公网安备34019202002308
